CapsoVision CV
NASDAQ CV
$5.97 -0.15 (-2.45%)
At close: Aug 20, 2026 · 3:00 PM UTC

CapsoVision (CV) Other Non Operating Income (2024 - 2026)

CapsoVision (CV) posted Other Non Operating Income of -$34000.0 for Q3 2025, down 209.09% sequentially from -$11000.0 in Q2 2025, and down 3500.0% YoY from $1000.0 in Q3 2024.

CapsoVision (CV) Other Non Operating Income (2024 - 2026) Analysis & Trends

CapsoVision has reported Other Non Operating Income for 2 years, with the latest figure at -$34000.0 in Q3 2025.

  • Quarterly Other Non Operating Income fell 3500.0% year-over-year to -$34000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$43000.0 (changed N/A YoY) and the FY2025 annual result came in at -$44000.0, down 1200.0% from the prior year.
  • Other Non Operating Income slipped to -$34000.0 in Q3 2025 per CV's latest filing, from -$11000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $2000.0 in Q4 2024 and troughed at -$34000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.60 Bn 194.00 Bn 7.27 Bn
2 Stryker 127.14 Bn 123.66 Bn 4.50 Bn
3 Medtronic 118.89 Bn 109.67 Bn 6.41 Bn
4 Boston Scientific 73.11 Bn 72.57 Bn 3.85 Bn
5 Edwards Lifesciences 52.03 Bn 47.78 Bn 1.35 Bn
6 Dexcom 34.31 Bn 32.36 Bn 830.00 Mn
7 GE HealthCare Technologies 33.78 Bn 31.67 Bn 2.18 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn
9 Steris 23.03 Bn 22.55 Bn 684.20 Mn
10 CapsoVision 298.13 Mn 289.05 Mn 1.87 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 17,000.00
Sep 30, 2025 -34,000.00
Jun 30, 2025 -11,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 1,000.00